Fitusiran is under investigation in clinical trial NCT02554773 (An Open-label Extension Study of an Investigational Drug, ALN-AT3SC, in Patients With Moderate or Severe Hemophilia A or B).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.